Oral spherical carbon adsorbent

Class

Oral spherical carbon adsorbent (non-absorbed activated-carbon microsphere)

Pathway

Adsorbs uremic-toxin precursors (notably indole, the precursor of indoxyl sulfate) in the gut lumen, reducing protein-bound uremic toxin accumulation and slowing CKD progression

Notes

original target text: Oral spherical carbon adsorbent (non-absorbed activated-carbon microsphere)

This mechanism describes a non-absorbed oral adsorbent rather than a conventional drug target—it does not bind a receptor or enzyme but acts physically within the gut lumen. Its intended substrate is indole, a compound produced when gut bacteria metabolize dietary tryptophan. Indole is absorbed into the bloodstream and converted in the liver to indoxyl sulfate, one of several protein-bound uremic toxins that accumulate as kidney function declines in chronic kidney disease (CKD). Because these toxins bind tightly to plasma proteins, they are poorly removed by the kidneys or by dialysis, and their buildup is associated with vascular injury, oxidative stress, and progressive kidney scarring. By adsorbing indole before it is absorbed, the carbon microsphere reduces the raw material available for toxin formation, aiming to lower circulating uremic toxin levels over time. The biological rationale is preventive rather than symptomatic: intercepting a toxin precursor at its source in the intestine, rather than trying to clear the toxin once it is already protein-bound in the blood. This approach is relevant broadly to CKD management, particularly in earlier stages where slowing the accumulation of uremic toxins may help delay progression toward more advanced kidney disease.